Chromosome 22q11.2 Deletion Syndrome | CHOP Research Institute
 

Chromosome 22q11.2 Deletion Syndrome

Published on
Nov 5, 2025
Targeting the mitochondria improved blood-brain barrier function and cognition in a preclinical model of the genetic disorder.
Published on
Nov 26, 2024
Donna McDonald-McGinn, Director of the 22q and You Center, received a Dedication to Service award for her lifelong 22q11.2 deletion syndrome work.
Published on
Mar 27, 2024
Srdjan Joksimovic, PharmD, PhD, our March Faculty Spotlight, studies the neuronal circuitry that underlies the mechanisms of complex brain disorders.
Published on
Jul 19, 2021
CHOP and Penn researchers find connection between mitochondrial function and mental illness in patients with a rare genetic disorder.

The Sullivan Lab has a broad interest in immune dysfunction. This can underlie susceptibility to infections and autoimmunity and inflammation. The investigators in the lab use cutting-edge approaches to investigate cause in individual patients and to look at population-wide causes of disease.

Dr. Sullivan's research focuses on new and rare immunodeficiencies. She has a long-standing interest in one of the most common of the primary immunodeficiencies – chromosome 22q11.2 deletion syndrome. She also investigates common variable immunodeficiency, as well as the genetics and epigenetics of systemic lupus erythematosus.

E-mail:
sullivank [at] chop.edu